🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to demonstrate the effectiveness and safety of...
Status
Completed
Location
Multiple Locations
Start Date
2002-11
Trial ID
NCT00214526
Treatments Being Tested
Objective: To evaluate non-inferiority of Trimbow, an approved therapy for ...
Status
Unknown
Location
Multiple Locations
Start Date
2021-02-15
Trial ID
NCT04737655
Cat allergy is an increasingly prevalent condition, affecting 10-15% of pat...
Status
Completed
Location
Alpha Medical Research
Start Date
2009-03
Trial ID
NCT00867906
The purpose of this Phase III study is to evaluate the efficacy and safety ...
Status
Completed
Location
Research Site
Start Date
2022-01-03
Trial ID
NCT05166889
Treatments Being Tested
To establish the feasibility of stopping inhaled steroids and switching or ...
Status
Completed
Location
Prince Philip Hospital
Start Date
2017-05-17
Trial ID
NCT03527927
Treatments Being Tested
The purpose of this study is to test the body's response to several doses o...
Status
Completed
Location
Quotient Clinical Ltd
Start Date
2014-07
Trial ID
NCT02232087
Treatments Being Tested
The primary purpose of this study is to demonstrate the equivalence of bude...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-10-17
Trial ID
NCT06340581
The purpose of the study is to provide long term safety data of NVA237. Thi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-10
Trial ID
NCT01697696
Treatments Being Tested
Primary Objective: To evaluate the efficacy of dupilumab in children 6 to ...
Status
Completed
Location
Investigational Site Number 840031
Start Date
2017-04-21
Trial ID
NCT02948959
Treatments Being Tested
This study will evaluate the efficacy and safety data of AZD8871 in patient...
Status
Completed
Location
Research Site
Start Date
2018-10-10
Trial ID
NCT03645434
Treatments Being Tested